• Amyloid Beta-Peptide (1-40) (human): Research Guide

  2026-09-30

  Amyloid Beta-Peptide (1-40) (human) is a synthetic 40-residue Aβ40 reagent for amyloid fibril formation study, neurotoxicity mechanism investigation, and Alzheimer's disease research. Its experimental meaning depends on peptide preparation state, because monomeric Aβ can produce cellular effects that are not interchangeable with fibrillar or mixed aggregates.

• Cycloheximide and Mitochondrial Translation Logic

  2026-09-30

  Cycloheximide is more than a translation-arrest reagent: it is a strategic perturbation for testing whether newly synthesized proteins sustain mitochondrial homeostasis, oxidative-stress resistance, and apoptosis control. This article connects the compound’s mechanism to recent findings on the DCLRE1A–SYVN1 axis in age-related cataract research and outlines a rigorous translational workflow.

• Protein A/G Magnetic Co-IP/IP Kit Workflow

  2026-09-29

  Translate the RNF8–DAPK1 interaction workflow from ischemic-stroke research into a practical, magnetic-bead assay strategy. The Protein A/G Magnetic Co-IP/IP Kit combines Fc-selective capture, rapid separation, and flexible elution for protein-complex isolation, western blotting, and carefully planned mass-spectrometry workflows.

• TRPV1+ Nerves Suppress Inflammation via Reflexes

  2026-09-29

  Song et al. show that activating TRPV1+ peripheral sensory nerves at the nape can suppress systemic inflammation through coordinated somato-autonomic reflexes. The study connects peripheral stimulation with brainstem activation, corticosterone and catecholamine release, autonomic-splenic signaling, and inflammation-related transcriptional changes in the spleen.

• SUMO Protease (Ulp): Practical Cleavage Guide

  2026-09-28

  SUMO Protease (Ulp), an Ulp1 protease, removes SUMO fusion tags by cleaving immediately downstream of the SUMO C-terminal Gly-Gly motif. It is intended for SUMO-tagged recombinant proteins and controlled purification workflows, not for unrelated affinity tags or as a universal protein degradation reagent.

• Idoxuridine (B1773): Assay Design and Troubleshooting

  2026-09-28

  Learn how to use Idoxuridine (SKU B1773) as an experimental perturbation in antiviral and cell-based studies without confusing viral inhibition with host-cell toxicity. This scenario-driven guide covers solubility, controls, interpretation, storage, and practical supplier-selection criteria.

• Cy5 NHS ester(Et): Practical Labeling Guide

  2026-09-27

  Cy5 NHS ester(Et) provides a water-soluble fluorescent reagent for tagging primary amines in proteins, peptides, and other biomolecules. It suits immediate-use labeling for imaging and flow cytometry workflows, but not ethanol-based preparation or long-term storage of dye solutions.

• From Placental Necroptosis to Translational Decisions

  2026-09-26

  A recent rat and cell study links placental ischemia with necroptosis and tests cholinergic signaling as a way to reduce disease-associated changes. This article examines what the findings support, how to design stronger follow-up experiments, and where translation remains uncertain. It also clarifies the limited, separate role a tag-free recombinant mouse CD4 protein may play in research programs that include CD4-focused assays.

• Nicotine Signaling in CKD Progression: Evidence and Limits

  2026-09-25

  Jain and Jaimes synthesize clinical and experimental evidence that nicotine may contribute to chronic kidney disease progression through nicotinic acetylcholine receptors, oxidative stress, and profibrotic signaling. Their review connects human observations with animal models while emphasizing that nicotine is only one component of tobacco smoke and that its contribution to kidney injury is not fully resolved.

• Protein A/G Magnetic Beads in IVDD Research

  2026-09-25

  Use Protein A/G Magnetic Beads to turn a disc-degeneration pathway hypothesis into testable immunoprecipitation and interaction experiments. A practical workflow connects the reported acacetin–MAPK1/HMOX1 findings to antibody capture, co-IP, and orthogonal validation—without treating pathway association as proof of direct binding.

• PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma

  2026-09-24

  A 2025 study links PDHA1 K83 succinylation to α-ketoglutaric acid accumulation and reduced macrophage antigen presentation in cholangiocarcinoma. Its findings outline a metabolic route to immune escape and report that CPI-613 can improve tumor sensitivity to gemcitabine and cisplatin in the study models.

• Amyloid Beta-Peptide (1-40): Assay Workflow

  2026-09-24

  Build a controlled Aβ40 workflow that separates bulk aggregation from membrane-associated effects and tests how calcium and order of addition alter the readout. Practical starting conditions, controls, and troubleshooting guidance help researchers use this Alzheimer's disease research peptide without treating an in-vitro model as a complete disease replica.

• AEBSF.HCl: Protease Context in Translational Research

  2026-09-23

  AEBSF.HCl is a broad-spectrum serine protease inhibitor with established uses in APP-processing and cell-lysis studies. This article examines how to use it as a mechanistic perturbation—and why it should not be mistaken for a direct probe of the cathepsin pathway implicated in MLKL-driven necroptosis.

• BCA Protein Quantification Kit K4102 Guide

  2026-09-23

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 measures low-concentration total protein in biochemical samples, including many detergent-containing preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and is not validated for diagnostic, clinical, or medical use.

• Amyloid β-Peptide (1-42): Practical Assay Guide

  2026-09-22

  Build more informative Aβ42 experiments by connecting aggregation state, microglial clearance, neuronal viability, and ion-channel readouts. This workflow translates a key P2Y2-receptor study into practical assay choices while addressing peptide handling, aggregation variability, and troubleshooting.

7983 records 1/533 page Next 12345 下5页 Last page